Abcam Stock Today

ABCM -  USA Stock  

USD 17.84  0.61  3.31%

Market Performance
0 of 100
Odds Of Distress
Less than 28
Abcam Plc is selling for 17.84 as of the 16th of January 2022. This is a -3.31 percent decrease since the beginning of the trading day. The stock's lowest day price was 17.79. Abcam Plc has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Abcam Plc ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of January 2020 and ending today, the 16th of January 2022. Click here to learn more.
Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. The company has 228.88 M outstanding shares of which 208.34 K shares are presently shorted by private and institutional investors with about 1.53 trading days to cover. More on Abcam Plc ADR

Abcam Plc Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Abcam Plc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abcam Plc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Abcam Plc ADR generated a negative expected return over the last 90 days
Abcam Plc ADR was previously known as Abcam Plc and was traded on NASDAQ Exchange under the symbol ABCZY.
Abcam Plc Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Abcam Plc ADR SEC Filings
Abcam Plc SEC Filings Security & Exchange Commission EDGAR Reports
Legal NameAbcam Plc ADR
Older SymbolABCZY
Average Analyst Recommendation
Analysts covering Abcam Plc report their recommendations after researching Abcam Plc's financial statements, talking to executives and customers, or listening in on Abcam Plc's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Abcam Plc ADR. The Abcam consensus assessment is calculated by taking the average forecast from all of the analysts covering Abcam Plc.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Abcam Plc ADR based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Abcam Plc ADR financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 6 - HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares201.5 M202.7 M
Slightly Down
Decreasing
Slightly volatile
Net Cash Flow from Operations68.2 M69.3 M
Fairly Down
Decreasing
Slightly volatile
Total Assets900.9 M948.2 M
Notably Down
Increasing
Slightly volatile
Total Liabilities223 M218.3 M
Fairly Up
Increasing
Slightly volatile
Current Assets342.2 M367.7 M
Significantly Down
Increasing
Slightly volatile
Current Liabilities92.9 M76.9 M
Fairly Up
Increasing
Slightly volatile
Total Debt124.9 M99.5 M
Significantly Up
Decreasing
Slightly volatile
Return on Average Assets0.01790.018
Slightly Down
Decreasing
Slightly volatile
Gross Margin0.840.82
Fairly Up
Increasing
Slightly volatile
Asset Turnover0.340.33
Fairly Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Abcam Plc's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Financial Strength
Abcam Plc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Abcam Plc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Abcam Plc's financial leverage. It provides some insight into what part of Abcam Plc's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Abcam Plc's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Abcam Plc deploys its capital and how much of that capital is borrowed.
Liquidity
Abcam Plc cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 110.5 M in liabilities with Debt to Equity (D/E) ratio of 0.17, which may suggest the company is not taking enough advantage from borrowing. Abcam Plc ADR has a current ratio of 4.68, suggesting that it is liquid enough and is able to pay its financial obligations when due.

Operating Cash Flow

68.21 MillionShare
Abcam Plc ADR (ABCM) is traded on NASDAQ Exchange in USA. It is located in Discovery Drive and employs 1,650 people. Abcam Plc ADR was previously known as Abcam Plc and was traded on NASDAQ Exchange under the symbol ABCZY. Abcam Plc is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with current market capitalization of 4.72 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abcam Plc's market, we take the total number of its shares issued and multiply it by Abcam Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Abcam Plc ADR conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 228.88 M outstanding shares of which 208.34 K shares are presently shorted by private and institutional investors with about 1.53 trading days to cover. Abcam Plc ADR currently holds about 219.9 M in cash with 71.9 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.97.
Check Abcam Plc Probability Of Bankruptcy
Ownership
Abcam Plc ADR retains a total of 228.88 Million outstanding shares. Almost 90.0 percent of Abcam Plc outstanding shares are held by regular investors with 0.0 (percent) owned by insiders and only 10.22 % by other corporate entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Abcam Ownership Details

Abcam Stock Price Odds Analysis

What are Abcam Plc's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Abcam Plc jumping above the current price in 90 days from now is close to 99%. The Abcam Plc ADR probability density function shows the probability of Abcam Plc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Abcam Plc has a beta of 0.8633. This suggests Abcam Plc ADR market returns are highly reactive to returns on the market. As the market goes up or down, Abcam Plc is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Abcam Plc ADR is significantly underperforming DOW.
 Odds Down 17.84HorizonTargetOdds Up 17.84 
0.00%90 days
 17.84 
100.00%
Based on a normal probability distribution, the odds of Abcam Plc to move above the current price in 90 days from now is close to 99 (This Abcam Plc ADR probability density function shows the probability of Abcam Stock to fall within a particular range of prices over 90 days) .

Abcam Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Abcam Plc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Abcam Plc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Abcam Plc's value.
InstituionSecurity TypeTotal SharesValue
Diversified Trust CoCommon Shares9.8 K230 K
Harbor Investment Advisory LlcCommon Shares4.1 K96 K
View Abcam Plc Diagnostics

Abcam Plc Historical Income Statement

Abcam Plc ADR Income Statement is one of the three primary financial statements used for reporting Abcam's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Abcam Plc ADR revenue and expense. Abcam Plc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Abcam Plc Operating Income is relatively stable at the moment as compared to the past year. The company's current value of Operating Income is estimated at 26.66 Million. Research and Development Expense is expected to hike to about 30.1 M this year, although the value of Gross Profit will most likely fall to nearly 239.2 M. View More Fundamentals

Abcam Stock Against Markets

Picking the right benchmark for Abcam Plc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Abcam Plc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Abcam Plc is critical whether you are bullish or bearish towards Abcam Plc ADR at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abcam Plc without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module
Please continue to Trending Equities. Note that the Abcam Plc ADR information on this page should be used as a complementary analysis to other Abcam Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Abcam Stock analysis

When running Abcam Plc ADR price analysis, check to measure Abcam Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcam Plc is operating at the current time. Most of Abcam Plc's value examination focuses on studying past and present price action to predict the probability of Abcam Plc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abcam Plc's price. Additionally, you may evaluate how the addition of Abcam Plc to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Is Abcam Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcam Plc. If investors know Abcam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcam Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abcam Plc ADR is measured differently than its book value, which is the value of Abcam that is recorded on the company's balance sheet. Investors also form their own opinion of Abcam Plc's value that differs from its market value or its book value, called intrinsic value, which is Abcam Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcam Plc's market value can be influenced by many factors that don't directly affect Abcam Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcam Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine Abcam Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcam Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.